By Stacie Prada Lately, I’ve been pausing periodically throughout each day to ask myself, “How do I want to show up today?” It only takes a moment, just enough time for a brief inhale and exhale. It allows me to … Continue reading → Source:…
Tweet In the UK people have a real issue with non-human primate research and there is essentially no MS related work ongoing in the UK. You know we love our furry friends and in the 1980s when I worked in a place where people worked…
Several (OK, many) years ago, I was having lunch with a group of fellow Green Berets when a news story appeared on the TV. The report covered a recent tragedy, and during an interview with a survivor, it was mentioned that one of the victims…
The University of California San Francisco (UCSF) is teaming up with Nektar Therapeutics to study the potential of NKTR-0165, an experimental antibody that activates the tumor necrosis factor receptor type 2 (TNFR2), to treat multiple sclerosis (MS). UCSF neurologist Stephen L. Hauser, MD, and his…
Breastfeeding for longer during infancy may delay the onset of multiple sclerosis (MS) and slow its progression for people who later develop the disease, according to a study from Turkey. Researchers found that adults with MS who had been breastfed for more than six months…
Gràcies a la generositat de Teaming, la plataforma de micromecenatge més gran d’Espanya, hem pogut oferir 7 entrades gratuïtes en una llotja del Palau de la Música Catalana per assistir al concert de la Franz Schubert Filharmonia, celebrat el dimecres 11 de febrer a les…
Tweet Hartung DM et al. Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 202116 e200597 Neurol Clin Practise 2026 https://doi.org/10.1212/CPJ.00000000002005 This is a paper that tweaked my interest and says to the people in the UK to spare a thought for…
Tweet You wanted it you got it the hottest band in the World….Piss I meant you wanted it you got…..Neurologists feeding from the Pharma trough. You may have noted that the costs of MS drugs in the USA, are particularly high. Well if you want…
Canary Speech and Intermountain Ventures are collaborating to test whether subtle changes in a person’s voice can help identify multiple sclerosis (MS), potentially paving the way for noninvasive tools to diagnose the disease faster. The research will rely on Canary’s vocal biomarker technology and be led…
Immunic Therapeutics has closed a private placement that could provide up to $400 million to support the company’s Phase 3 clinical program of vidofludimus calcium in multiple sclerosis (MS) and help fund its transition into a commercial-stage company as it prepares for potential regulatory approval…